DK1492539T3 - Statin-terapi til forögelse af kognitiv funktion - Google Patents
Statin-terapi til forögelse af kognitiv funktionInfo
- Publication number
- DK1492539T3 DK1492539T3 DK03745196T DK03745196T DK1492539T3 DK 1492539 T3 DK1492539 T3 DK 1492539T3 DK 03745196 T DK03745196 T DK 03745196T DK 03745196 T DK03745196 T DK 03745196T DK 1492539 T3 DK1492539 T3 DK 1492539T3
- Authority
- DK
- Denmark
- Prior art keywords
- cognitive function
- statin
- statin therapy
- enhance cognitive
- galantamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36928502P | 2002-04-02 | 2002-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1492539T3 true DK1492539T3 (da) | 2006-10-30 |
Family
ID=28675573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03745196T DK1492539T3 (da) | 2002-04-02 | 2003-03-28 | Statin-terapi til forögelse af kognitiv funktion |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1492539B1 (de) |
JP (1) | JP2005525391A (de) |
KR (1) | KR100986194B1 (de) |
CN (1) | CN100528164C (de) |
AT (1) | ATE331523T1 (de) |
AU (1) | AU2003226753B2 (de) |
BR (1) | BR0308293A (de) |
CA (1) | CA2480275C (de) |
CY (1) | CY1105545T1 (de) |
DE (1) | DE60306503T2 (de) |
DK (1) | DK1492539T3 (de) |
EA (1) | EA013069B1 (de) |
ES (1) | ES2268393T3 (de) |
HK (1) | HK1079688A1 (de) |
IL (2) | IL164317A0 (de) |
MX (1) | MXPA04009535A (de) |
NO (1) | NO20044698L (de) |
NZ (1) | NZ536111A (de) |
PL (1) | PL211160B1 (de) |
PT (1) | PT1492539E (de) |
UA (1) | UA79605C2 (de) |
WO (1) | WO2003082298A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1603548A4 (de) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen |
MXPA06011969A (es) * | 2004-04-14 | 2006-12-15 | Warner Lambert Co | Combinacion terapeutica para tratamiento de la enfermedad de alzheimer. |
WO2005123068A2 (en) * | 2004-06-08 | 2005-12-29 | Axonyx, Inc. | Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
GB0607946D0 (en) * | 2006-04-21 | 2006-05-31 | Minster Res The Ltd | Mono and combination therapy |
EP2076288A2 (de) * | 2006-09-22 | 2009-07-08 | Braincells, Inc. | Kombination aus einem hmg-coa-reduktasehemmer und einem zweiten neurogenen wirkstoff zur behandlung einer nervensystemerkrankung und erhöhung von neurogenese |
TWI432195B (zh) | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
US20160303146A1 (en) * | 2013-12-13 | 2016-10-20 | David A. TABACZYNSKI | Inhibition of isoprenoid biosynthetic pathways to treat neuroinflammatory disorders |
-
2003
- 2003-03-28 EP EP03745196A patent/EP1492539B1/de not_active Expired - Lifetime
- 2003-03-28 AT AT03745196T patent/ATE331523T1/de active
- 2003-03-28 UA UA20040806803A patent/UA79605C2/uk unknown
- 2003-03-28 CN CNB038073854A patent/CN100528164C/zh not_active Expired - Fee Related
- 2003-03-28 EA EA200401295A patent/EA013069B1/ru not_active IP Right Cessation
- 2003-03-28 CA CA2480275A patent/CA2480275C/en not_active Expired - Fee Related
- 2003-03-28 PT PT03745196T patent/PT1492539E/pt unknown
- 2003-03-28 WO PCT/EP2003/003324 patent/WO2003082298A1/en active IP Right Grant
- 2003-03-28 JP JP2003579835A patent/JP2005525391A/ja active Pending
- 2003-03-28 AU AU2003226753A patent/AU2003226753B2/en not_active Ceased
- 2003-03-28 ES ES03745196T patent/ES2268393T3/es not_active Expired - Lifetime
- 2003-03-28 PL PL371551A patent/PL211160B1/pl unknown
- 2003-03-28 DK DK03745196T patent/DK1492539T3/da active
- 2003-03-28 IL IL16431703A patent/IL164317A0/xx unknown
- 2003-03-28 DE DE60306503T patent/DE60306503T2/de not_active Expired - Lifetime
- 2003-03-28 BR BR0308293-8A patent/BR0308293A/pt not_active IP Right Cessation
- 2003-03-28 KR KR1020047013127A patent/KR100986194B1/ko active IP Right Grant
- 2003-03-28 NZ NZ536111A patent/NZ536111A/xx not_active IP Right Cessation
- 2003-03-28 MX MXPA04009535A patent/MXPA04009535A/es active IP Right Grant
-
2004
- 2004-09-28 IL IL164317A patent/IL164317A/en not_active IP Right Cessation
- 2004-10-29 NO NO20044698A patent/NO20044698L/no not_active Application Discontinuation
-
2005
- 2005-12-21 HK HK05111808.4A patent/HK1079688A1/xx not_active IP Right Cessation
-
2006
- 2006-09-27 CY CY20061101397T patent/CY1105545T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2480275C (en) | 2011-08-16 |
PL211160B1 (pl) | 2012-04-30 |
DE60306503T2 (de) | 2007-06-21 |
AU2003226753A1 (en) | 2003-10-13 |
EP1492539B1 (de) | 2006-06-28 |
DE60306503D1 (de) | 2006-08-10 |
PL371551A1 (en) | 2005-06-27 |
NO20044698L (no) | 2004-10-29 |
CY1105545T1 (el) | 2010-07-28 |
IL164317A0 (en) | 2005-12-18 |
EA013069B1 (ru) | 2010-02-26 |
JP2005525391A (ja) | 2005-08-25 |
KR100986194B1 (ko) | 2010-10-07 |
CN1642555A (zh) | 2005-07-20 |
PT1492539E (pt) | 2006-11-30 |
NZ536111A (en) | 2006-03-31 |
CA2480275A1 (en) | 2003-10-09 |
IL164317A (en) | 2010-04-29 |
EP1492539A1 (de) | 2005-01-05 |
AU2003226753B2 (en) | 2007-06-28 |
ES2268393T3 (es) | 2007-03-16 |
EA200401295A1 (ru) | 2005-02-24 |
HK1079688A1 (en) | 2006-04-13 |
MXPA04009535A (es) | 2005-01-25 |
WO2003082298A1 (en) | 2003-10-09 |
CN100528164C (zh) | 2009-08-19 |
BR0308293A (pt) | 2004-12-28 |
UA79605C2 (en) | 2007-07-10 |
KR20040096608A (ko) | 2004-11-16 |
ATE331523T1 (de) | 2006-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
NO20053077L (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
BRPI0415858A (pt) | compostos de medicamentos terapêuticos modificados por tocoferol | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
HK1079688A1 (en) | Statin product for enhancing cognitive maintenance | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
DK1656131T3 (da) | Anvendelse af betain til behandling claudicatio intermittens | |
BG105342A (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
ATE404192T1 (de) | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration | |
EP1603595A4 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
DK0707477T3 (da) | Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo | |
HUP0300043A2 (en) | Method and composition for the treatment of pain | |
DE60122764D1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
WO2003066806A3 (en) | Therapeutic use of aziridino compounds | |
ATE334675T1 (de) | Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole | |
ATE353221T1 (de) | Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa |